Search - tctmd.com

Displaying 401 - 420 of 685

Sort: Relevancy | Date

Presentation TCT 2017

Predicting the Future: Will the Ongoing GALILEO and ENVISAGE AF Trials Change How We Anticoagulate Patients After TAVR?

Presenter: David H. Adams, Ted Feldman, Vinod H. Thourani

October 30, 2017

Presentation TCT 2017

Preprocedural and Intraprocedural Imaging to Guide Ablation

Presenter: Srihari S. Naidu, Paul Sorajja, Sherif F. Nagueh

October 30, 2017

Presentation TCT 2017

Predicting the Future: Will the Ongoing LOW RISK TAVR Trials Change How We Treat Low Surgical Risk Patients With Aortic Stenosis?

Presenter: David H. Adams, Ted Feldman, Craig R. Smith

October 30, 2017

Presentation TCT 2017

Contemporary Alcohol Septal Ablation Techniques

Presenter: Srihari S. Naidu, Paul Sorajja, Valerian Fernandes

October 30, 2017

Presentation TCT 2017

Patient Selection for Alcohol Septal Ablation

Presenter: Srihari S. Naidu, Paul Sorajja

October 30, 2017

Presentation TCT 2017

Predicting The Future: Will the Ongoing DES 3-Month DAPT Studies With Synergy and Xience Change How We Treat High Risk Bleeding Patients?

Presenter: C. Michael Gibson, Stephan Windecker

October 30, 2017

Presentation TCT 2017

Predicting The Future: Will the ABSORB III/IV Ten-Year Results Change How We Currently View Bioresorbable Vascular Scaffolds?

Presenter: C. Michael Gibson, Stephan Windecker, Stephan Achenbach

October 30, 2017

Presentation TCT 2017

Predicting the Future: Will the Ongoing TWILIGHT and GLOBAL LEADERS Trials Change The Current Recommended Approach to Chronic Antiplatelet Therapy?

Presenter: C. Michael Gibson, Stephan Windecker, Eric R. Bates

October 30, 2017

Presentation TCT 2017

Multimodality Imaging for HCM Diagnosis

Presenter: Morton J. Kern, Sherif F. Nagueh

October 30, 2017

Presentation TCT 2017

Diagnostic Performance of Virtual FFR Derived From Routine Coronary Angiography Using 1D Flow Modelling: Validation Against Conventional FFR

Presenter: Bernard De Bruyne, Evelyn S. Regar, Kevin Mohee

October 30, 2017

Presentation TCT 2017

Predicting the Future: Will the Ongoing COMPLETE Trial Change the Current Recommended Approach to Multivessel Disease in STEMI?

Presenter: C. Michael Gibson, Stephan Windecker, David Hildick-Smith

October 30, 2017

Presentation TCT 2017

The Hemodynamics of Diastology, LVOT Obstruction, and Exercise Physiology in HCM

Presenter: Morton J. Kern, Sherif F. Nagueh

October 30, 2017

Presentation TVT 2017

Selecting Patients for ViV and ViR: Can We Predict Success and Complications?

Presenter: Saibal Kar, Danny Dvir

June 15, 2017

Presentation TCT 2016

Cryptogenic Stroke, Thrombophilia, VTE, and PFO: Do We Know What To Do?

Presenter: Eustaquio Maria Onorato, Richard Smalling, Robert J. Sommer

November 01, 2016

Presentation TCT 2016

The REDUCE Trial: Will It Be Positive and What Will We Learn?

Presenter: Eustaquio Maria Onorato, Richard Smalling, John F. Rhodes

November 01, 2016

Presentation TCT 2016

What Should Be the Next Series of Clinical Trials in PFO Closure?

Presenter: Eustaquio Maria Onorato, Richard Smalling, John D. Carroll

November 01, 2016

Presentation TCT 2016

The Neurologist as the Gatekeeper of PFO Closure in the US: What is Cryptogenic Stroke and When Do Neurologists Think PFO Closure Is Needed?

Presenter: Eustaquio Maria Onorato, Richard Smalling, David E. Thaler

November 01, 2016

Presentation TCT 2016

Anticipating FDA approval of the Amplatzer PFO Occluder: Indications, Rational Dispersion of Technology, and Post-Approval Studies

Presenter: Eustaquio Maria Onorato, Richard Smalling

November 01, 2016

Presentation TCT 2016

Building a Successful PFO Closure Program

Presenter: John D. Carroll, Christian Spies

November 01, 2016

Presentation TCT 2016

Available Devices/Techniques for Closure of PFO

Presenter: John D. Carroll, Christian Spies, Michael J. Mullen

November 01, 2016

Advertisement

Predicting the Future: Will the Ongoing GALILEO and ENVISAGE AF Trials Change How We Anticoagulate Patients After TAVR?

Preprocedural and Intraprocedural Imaging to Guide Ablation

Predicting the Future: Will the Ongoing LOW RISK TAVR Trials Change How We Treat Low Surgical Risk Patients With Aortic Stenosis?

Contemporary Alcohol Septal Ablation Techniques

Patient Selection for Alcohol Septal Ablation

Predicting The Future: Will the Ongoing DES 3-Month DAPT Studies With Synergy and Xience Change How We Treat High Risk Bleeding Patients?

Predicting The Future: Will the ABSORB III/IV Ten-Year Results Change How We Currently View Bioresorbable Vascular Scaffolds?

Predicting the Future: Will the Ongoing TWILIGHT and GLOBAL LEADERS Trials Change The Current Recommended Approach to Chronic Antiplatelet Therapy?

Multimodality Imaging for HCM Diagnosis

Diagnostic Performance of Virtual FFR Derived From Routine Coronary Angiography Using 1D Flow Modelling: Validation Against Conventional FFR

Predicting the Future: Will the Ongoing COMPLETE Trial Change the Current Recommended Approach to Multivessel Disease in STEMI?

The Hemodynamics of Diastology, LVOT Obstruction, and Exercise Physiology in HCM

Selecting Patients for ViV and ViR: Can We Predict Success and Complications?

Cryptogenic Stroke, Thrombophilia, VTE, and PFO: Do We Know What To Do?

The REDUCE Trial: Will It Be Positive and What Will We Learn?

What Should Be the Next Series of Clinical Trials in PFO Closure?

The Neurologist as the Gatekeeper of PFO Closure in the US: What is Cryptogenic Stroke and When Do Neurologists Think PFO Closure Is Needed?

Anticipating FDA approval of the Amplatzer PFO Occluder: Indications, Rational Dispersion of Technology, and Post-Approval Studies

Building a Successful PFO Closure Program

Available Devices/Techniques for Closure of PFO

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content